Agglutination inhibition assay methods and reagents for psychoac

Details Agglutination inhibition assay methods and reagents for psychoac Agglutination inhibition assay methods and reagents for psychoac

1995-06-05

1998-11-24

Saunders, David

Chemistry: analytical and immunological testing

Involving an insoluble carrier for immobilizing immunochemicals

436520, 436521, 436533, 436534, 436547, 436815, 436816, 436822, 5303911, G01N 33531, G01N 33543, G01N 33546, G01N 33555

Patent

active

058405887

ABSTRACT:
Immunoassays of psychoactive drugs including psychotomimetic drugs, narcotic drugs, and tetrahydrocannabinols and treatment methods based on the antigenic properties of protein conjugates of these drugs. These methods are based upon treating the psychoactive substances as haptens and utilizing their protein conjugates to produce antibodies to the psychoactive materials themselves. The immunoassay methods include both agglutination and agglutination-inhibition reactions. The treatment methods include treatment or both exogenous, administered drugs (such as cannabinols, LSD, heroin and morphine) and endogenous substances (such as N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine, by active immunization and also passive immunization.

REFERENCES:
patent: 3088875 (1963-05-01), Fisk
patent: 3236732 (1966-02-01), Arquilla et al.
patent: 3639558 (1972-02-01), Csizmas et al.
patent: 3639559 (1972-02-01), Tax
patent: 3646346 (1972-02-01), Catt
patent: 3652761 (1972-03-01), Weetall et al.
patent: 3654090 (1972-04-01), Schurrs et al.
patent: 3690834 (1972-09-01), Goldstein et al.
patent: 3709868 (1973-01-01), Spector
patent: 3775253 (1973-11-01), Dieter et al.
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3852157 (1974-12-01), Rubenstein et al.
patent: 3940475 (1976-02-01), Gross
patent: 3992631 (1976-11-01), Harte
patent: 4308026 (1981-12-01), Mochida et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4663278 (1987-05-01), Dinello
patent: 4828985 (1989-05-01), Self
patent: 5677132 (1997-10-01), Strahilevitz
B. Van K. Weeman et al, Scand. Juur. Immunol. Supplement, vol. 7, No. 8, 1978, p. 77.
Williams et al Methods in Immunologyy and Immunochemistry, vol. 1, Academic Press, 1967, p. 142.
L. Goodfriend et al, in F. G. Peron et al (Eds.) Immunologic Methods in Steroid Determination, Appleton-Century-Crofts, 1970, pp. 31-32.
Adler et al, Jour. Immunol., 106, 1684-1685, 1971.
Butler, Jr., Jour. Immunol. Meth., 7, 1-24, 1975.
Mule et al, Immunoassays for Drugs Subject to Abuse, CRC Press, Inc., 1974.
Sevier et al, Clin. Chem., 27, 1797-1806, 1981.
Handbook of Analytical Toxicology, Irving Sunshine, Editor, The Chemical Rubber Company, Publisher; Cleveland, Ohio, 1969.
D.J. Berry et al., Bulletin on Narcotics, vol. 22(3), Jul.-Sep. 1970, United Nations Publication.
Harold V. Street, Journal of Chromatography, vol. 48, pp. 291-294, 1970.
H. Van Vunakis et al., Bioch. Pharmacol., vol. 18, pp. 393-404, 1969. (SIG.).
S. Spector and C. Parker, Science, vol. 168, pp. 1347-1348, 1970 (SIG.).
G.D. Niswender and A.R. Midgley, in: Immunological Methods in Steroid Determination, F.G. Peron and B.V. Caldwell Editors, Appleton-Century-Crofts Pub., New York, pp. 149-173, 1970. (SIG).
L. Levine, in: "Handbook of Experimental Immunology." D.M. Weir, Editor, F.A. Davis Comp. Pub., Philadelphia, pp. 707-719, 1970.
Handbook of Experimental Immunology, D.M. Weir Editor, F.A. Davis Comp., Philadelphia, 1970.
W.J. Herbert, in Reference 8, pp. 720-744. (SIG.).
D.A.J. Tyrrell, in Ref. 8, pp. 782-785. (SIG.).
F. Cua-Lim et al., J. Allergy, vol. 34, pp.142-154, 1968. (SIG.).
Ingraham, Proc. Soc. Exp. Biol. N.Y., vol. 99, p. 452-, 1958. (SIG.).
N.S. Ranadive and A.H. Sehon, Canad. J. Biochem., vol. 45, pp. 1701-1710, 1967.
S. Spector, in: Advances in Biochemical Psychopharmacology, vol. 1, E. Costa and P. Greengard Editors, pp. 181-190, Raven press, New York, 1969. (SIG.).
R.N. Pinckard and D.M. Weir, in Ref. 8, pp. 493-524.
"Immunologic Methods in Steroid Determination." F.G. Peron and B.V. Caldwell Editors, Appleton-Century-Croft, Pub., New York, 1970.
L. Goodfriend and A.H. Sehon, in Ref. 17. pp. 15-21.
M. Strahilevitz et al., Biological Psychiatry, vol. 3, pp. 227-236, 1971. (SIG.).
Fultrope et al., Brit. Med. J., pp. 1049-1054, Apr. 20, 1963.(SIG.).
J.R. Batchelor, in Ref. 8, pp. 988-1008. (SIG.).
E.A. Kabat and M.M. Mayer: Experimental Immunochemistry, p. 124, second edition, Charles C. Thomas, Pub., Springfield, Illinois, 1961.
I.H. Thorneycroft et al., in Ref. 17, pp. 63-81.
G.E. Abraham and W.D. Odell, In Ref. 17, pp. 87-112.
S. Spector, The Journal of Pharmacology and Experimental Therapeutics, vol. 178 (2), pp. 253-258, 1071.
K.J. Catt, In Protein and Polypeptide Hormones, Proceedings of the International Symposium, Leige, M. Margoulis, Editor, Excerpta Medica Foundation Pub. Amsterdam, pp. 639-645, 1969. (SIG.).
D.H. Campbell et al., Proc. Nat. Acad. Sci. USA, vol. 37, pp. 575-578, 1951.
A. Malley and D.H. Campbell, J. Am. Chem. Soc., vol. 85, pp. 487-488, 1963.
H. Van Vunakis, et al., The Journal of Pharacol. and Exp. Therapeutics, vol. 180 (2), pp. 514-521, 1972. (SIG.).
J.D. Teale et al., The Lancet, Sep. 7, 1974, pp. 553-555.

Affiliated with

Also associated with

Rating

Agglutination inhibition assay methods and reagents for psychoac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agglutination inhibition assay methods and reagents for psychoac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agglutination inhibition assay methods and reagents for psychoac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1701097